Clinical Trial Update: Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating potential interactions between Truvada and hormone therapy in HIV pre-exposure prophylaxis; completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• HIV Prevention
• Transgender Health

Drugs mentioned

• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: University of California, San Francisco | Conditions: HIV Prevention, Transgender Health | Phase 4 | Status: COMPLETED | Results posted: 2021-05-11